RGRX

RegeneRX Biopharmaceutic... (CE) (RGRX)

RegeneRX Biopharmaceuticals Inc (CE)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:RGRX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/08/15	05 : 01	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2023/08/08	04 : 57	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2023/07/12	06 : 13	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2023/07/11	06 : 19	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2023/07/07	05 : 35	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2023/07/07	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2023/06/26	19 : 01	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2023/06/21	19 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2023/05/16	05 : 25	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2023/04/12	05 : 32	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2022/11/15	06 : 09	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2022/08/13	05 : 16	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2022/05/20	06 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2022/05/20	06 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2022/05/20	06 : 09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2022/05/20	06 : 05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2022/05/20	06 : 05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2022/05/17	06 : 11	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2021/11/16	06 : 35	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2021/11/16	04 : 56	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2021/10/18	19 : 05	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2021/10/09	04 : 52	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2021/08/17	23 : 32	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2021/08/07	05 : 09	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2021/08/05	05 : 12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2021/08/05	05 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2021/08/05	05 : 07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2021/08/05	05 : 04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2021/07/23	06 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
2021/07/20	05 : 16	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)